Healthcare Intelligence
Physical Therapy & Rehabilitation
Real-time intelligence, expert analysis, and verified research for the Physical Therapy & Rehabilitation industry. Stay ahead in 3 minutes a day.
Stay ahead of Physical Therapy & Rehabilitation in 3 minutes a day.
Expert-verified intelligence delivered to your inbox every morning.
Free forever. No spam. Unsubscribe anytime.
Chinese AI robots transform global physical therapy market
Fourier's AI-powered rehabilitation robots doubled international sales, now serving 2,000+ institutions across 40 countries.
Read full articleSouth Korea caps manual therapy prices at $26 per session
Government regulation starting July 1 aims to stem $921M in insurance losses from unregulated pricing varying by 2,000-fold.
Read full articleKnee robot helps SMA children stand in 6 weeks
Beihang University's 0.96kg wearable robot increased muscle mass by 19% and doubled knee strength in clinical trial.
Read full articleMedtronic to acquire SPR Therapeutics for $650M
Deal adds temporary peripheral nerve stimulation tech for chronic pain, expanding non-opioid treatment options.
Read full articleTyvaso shows promise for IPF in Phase 3 trials
United Therapeutics' inhaled therapy significantly slowed lung function decline, plans FDA submission this summer.
Read full articleChinese AI robots transform global physical therapy market
Fourier's AI-powered rehabilitation robots doubled international sales, now serving 2,000+ institutions across 40 countries.
Read full articleSouth Korea caps manual therapy prices at $26 per session
Government regulation starting July 1 aims to stem $921M in insurance losses from unregulated pricing varying by 2,000-fold.
Read full articleKnee robot helps SMA children stand in 6 weeks
Beihang University's 0.96kg wearable robot increased muscle mass by 19% and doubled knee strength in clinical trial.
Read full articleMedtronic to acquire SPR Therapeutics for $650M
Deal adds temporary peripheral nerve stimulation tech for chronic pain, expanding non-opioid treatment options.
Read full articleTyvaso shows promise for IPF in Phase 3 trials
United Therapeutics' inhaled therapy significantly slowed lung function decline, plans FDA submission this summer.
Read full articleStay ahead of Physical Therapy & Rehabilitation in 3 minutes a day.
Live opportunity intelligence for your market, delivered to your inbox every morning. Read it over coffee.
Free forever. No spam. Unsubscribe anytime.